全文获取类型
收费全文 | 24059篇 |
免费 | 8399篇 |
国内免费 | 160篇 |
学科分类
医药卫生 | 32618篇 |
出版年
2021年 | 294篇 |
2020年 | 260篇 |
2018年 | 332篇 |
2017年 | 365篇 |
2016年 | 535篇 |
2015年 | 860篇 |
2014年 | 1461篇 |
2013年 | 2092篇 |
2012年 | 630篇 |
2011年 | 534篇 |
2010年 | 1151篇 |
2009年 | 1256篇 |
2008年 | 494篇 |
2007年 | 296篇 |
2006年 | 423篇 |
2005年 | 347篇 |
2004年 | 308篇 |
2002年 | 289篇 |
2001年 | 430篇 |
2000年 | 341篇 |
1999年 | 551篇 |
1998年 | 792篇 |
1997年 | 755篇 |
1996年 | 800篇 |
1995年 | 767篇 |
1994年 | 654篇 |
1993年 | 605篇 |
1992年 | 592篇 |
1991年 | 565篇 |
1990年 | 503篇 |
1989年 | 594篇 |
1988年 | 620篇 |
1987年 | 604篇 |
1986年 | 562篇 |
1985年 | 597篇 |
1984年 | 536篇 |
1983年 | 524篇 |
1982年 | 585篇 |
1981年 | 547篇 |
1980年 | 528篇 |
1979年 | 507篇 |
1978年 | 500篇 |
1977年 | 501篇 |
1976年 | 436篇 |
1975年 | 391篇 |
1974年 | 353篇 |
1973年 | 333篇 |
1972年 | 333篇 |
1971年 | 304篇 |
1970年 | 255篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
4.
5.
Louis Anthony Cox Jr. 《Critical reviews in toxicology》2019,49(7):614-635
AbstractCan a single fiber of amphibole asbestos increase the risk of lung cancer or malignant mesothelioma (MM)? Traditional linear no-threshold (LNT) risk assessment assumptions imply that the answer is yes: there is no safe exposure level. This paper draws on recent scientific progress in inflammation biology, especially elucidation of the activation thresholds for NLRP3 inflammasomes and resulting chronic inflammation, to model dose-response relationships for malignant mesothelioma and lung cancer risks caused by asbestos exposures. The modeling integrates a physiologically based pharmacokinetics (PBPK) front end with inflammation-driven two-stage clonal expansion (I-TSCE) models of carcinogenesis to describe how exposure leads to chronic inflammation, which in turn promotes carcinogenesis. Together, the combined PBPK and I-TSCE modeling predict that there are practical thresholds for exposure concentration below which asbestos exposure does not cause chronic inflammation in less than a lifetime, and therefore does not increase chronic inflammation-dependent cancer risks. Quantitative examples using model parameter estimates drawn from the literature suggest that practical thresholds may be within about a factor of 2 of some past exposure levels for some workers. The I-TSCE modeling framework explains previous puzzling aspects of asbestos epidemiology, such as why age at first exposure is a better predictor of lifetime MM risk than exposure duration. It may be a valuable tool for risk analysts when LNT assumptions are not justified due to inflammation response thresholds mediating dose-response relationships. 相似文献
6.
7.
Alicia M. Blessing MD PhD Janice M. Santiago-O'Farrill MD PhD Weiqun Mao BS MD Lan Pang BS MD Jing Ning MD PhD Daewoo Pak MD PhD Lakshmi Reddy Bollu MD PhD Philip Rask BS MD LaKesla Iles BS MD Hailing Yang PhD MD Samantha Tran BS MD Ezzeddine Elmir BS MD Geoffrey Bartholomeusz MD PhD Robert Langley MD PhD Zhen Lu MD Robert C. Bast Jr MD 《Cancer》2020,126(15):3579-3592
8.
9.
Debora Sarzi Sartori Antônia Larangeira de Almeida Gabriel Santana Pereira de Oliveira Hiram Larangeira de Almeida Jr 《Anais brasileiros de dermatologia》2022,97(2):240-242
Panitumumab is a monoclonal antibody against the epidermal growth factor receptor used in metastatic colorectal cancer; in addition to tumor cells, it acts on epidermal keratinocytes and on the outer root sheath and presents skin toxicity in up to 90% of cases. A scanning electron microscope was used to examine the eyelashes and hairs of a 65-year-old patient with eyelash trichomegaly, curly hair, and paronychia undergoing treatment with panitumumab. Grooving in the hair shafts were identified, which were more evident in the eyelashes. Similar to oral epidermal growth factor inhibitors (erlotinib and gefitinib), panitumumab can cause acquired pili canaliculi. 相似文献
10.
Jennifer C. Sasaki Ashley Allemang Steven M. Bryce Laura Custer Kerry L. Dearfield Yasmin Dietz Azeddine Elhajouji Patricia A. Escobar Albert J. Fornace Jr Roland Froetschl Sheila Galloway Ulrike Hemmann Giel Hendriks Heng-Hong Li Mirjam Luijten Gladys Ouedraogo Lauren Peel Stefan Pfuhler Daniel J. Roberts Véronique Thybaud Jan van Benthem Carole L. Yauk Maik Schuler 《Environmental and molecular mutagenesis》2020,61(1):114-134
In May 2017, the Health and Environmental Sciences Institute's Genetic Toxicology Technical Committee hosted a workshop to discuss whether mode of action (MOA) investigation is enhanced through the application of the adverse outcome pathway (AOP) framework. As AOPs are a relatively new approach in genetic toxicology, this report describes how AOPs could be harnessed to advance MOA analysis of genotoxicity pathways using five example case studies. Each of these genetic toxicology AOPs proposed for further development includes the relevant molecular initiating events, key events, and adverse outcomes (AOs), identification and/or further development of the appropriate assays to link an agent to these events, and discussion regarding the biological plausibility of the proposed AOP. A key difference between these proposed genetic toxicology AOPs versus traditional AOPs is that the AO is a genetic toxicology endpoint of potential significance in risk characterization, in contrast to an adverse state of an organism or a population. The first two detailed case studies describe provisional AOPs for aurora kinase inhibition and tubulin binding, leading to the common AO of aneuploidy. The remaining three case studies highlight provisional AOPs that lead to chromosome breakage or mutation via indirect DNA interaction (inhibition of topoisomerase II, production of cellular reactive oxygen species, and inhibition of DNA synthesis). These case studies serve as starting points for genotoxicity AOPs that could ultimately be published and utilized by the broader toxicology community and illustrate the practical considerations and evidence required to formalize such AOPs so that they may be applied to genetic toxicity evaluation schemes. Environ. Mol. Mutagen. 61:114–134, 2020. © 2019 Wiley Periodicals, Inc. 相似文献